OVERVIEW

ACC CardiaCast: The Cardio-Protective Nature of DM Pharmacotherapies is organized by American College of Cardiology (ACC).

Issued Date: April 18, 2018
Term of Approval/Date of CME/MOC/CNE Expiration: April 18, 2021

Target Audience:
This activity is primarily intended for general adult cardiologists and the cardiovascular care team (nurse practitioners, registered nurses, physician assistants and pharmacists). Endocrinologists and primary care physicians may also benefit from this education.

Credit Offered:
• CME:0.25
• CNE:0.25
• COP:0.25
• MOC:0.25

Description:
The Cardio-Protective Nature of DM Pharmacotherapies, part of the ACC course CVD and DM: Lifting the Burden of Cardiovascular Disease and Diabetes. In this podcast, you will review an article discussing calcium scores and risk reclassification, along with examining DM pharmacotherapy and CVD co-morbidities.

Learner Objectives:
Upon completing this activity, learners should be able to:
• Identify the cardio-protective potential of DM pharmacotherapies.

Additional details will be posted as soon as they are available.